These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32424261)

  • 1. Association between metformin medication, genetic variation and prostate cancer risk.
    Lee MJ; Jayalath VH; Xu W; Lu L; Freedland SJ; Fleshner NE; Kulkarni GS; Finelli A; van der Kwast TH; Hamilton RJ
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):96-105. PubMed ID: 32424261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.
    Lindstrom S; Schumacher F; Siddiq A; Travis RC; Campa D; Berndt SI; Diver WR; Severi G; Allen N; Andriole G; Bueno-de-Mesquita B; Chanock SJ; Crawford D; Gaziano JM; Giles GG; Giovannucci E; Guo C; Haiman CA; Hayes RB; Halkjaer J; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Navarro C; Riboli E; Sacerdote C; Stampfer M; Stram DO; Thun MJ; Trichopoulos D; Virtamo J; Weinstein SJ; Yeager M; Henderson B; Ma J; Le Marchand L; Albanes D; Kraft P
    PLoS One; 2011 Feb; 6(2):e17142. PubMed ID: 21390317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of Genes Involved in Glucose and Energy Metabolic Pathways and Prostate Cancer: Interplay with Metformin.
    Murtola TJ; Wahlfors T; Haring A; Taari K; Stenman UH; Tammela TL; ; Schleutker J; Auvinen A
    Eur Urol; 2015 Dec; 68(6):1089-97. PubMed ID: 25819720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
    Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
    Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide Scan Identifies Role for AOX1 in Prostate Cancer Survival.
    Li W; Middha M; Bicak M; Sjoberg DD; Vertosick E; Dahlin A; Häggström C; Hallmans G; Rönn AC; Stattin P; Melander O; Ulmert D; Lilja H; Klein RJ
    Eur Urol; 2018 Dec; 74(6):710-719. PubMed ID: 30289108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin use and risk of prostate cancer: results from the REDUCE study.
    Feng T; Sun X; Howard LE; Vidal AC; Gaines AR; Moreira DM; Castro-Santamaria R; Andriole GL; Freedland SJ
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1055-60. PubMed ID: 26353947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between metformin use and risk of prostate cancer and its grade.
    Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of multiple risk-associated single nucleotide polymorphisms versus prostate-specific antigen at baseline to predict prostate cancer in unscreened men.
    Klein RJ; Hallden C; Gupta A; Savage CJ; Dahlin A; Bjartell A; Manjer J; Scardino PT; Ulmert D; Wallström P; Vickers AJ; Lilja H
    Eur Urol; 2012 Mar; 61(3):471-7. PubMed ID: 22101116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of androgen metabolism gene polymorphisms with prostate cancer risk and androgen concentrations: Results from the Prostate Cancer Prevention Trial.
    Price DK; Chau CH; Till C; Goodman PJ; Leach RJ; Johnson-Pais TL; Hsing AW; Hoque A; Parnes HL; Schenk JM; Tangen CM; Thompson IM; Reichardt JK; Figg WD
    Cancer; 2016 Aug; 122(15):2332-40. PubMed ID: 27164191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses.
    Lu Y; Sun J; Kader AK; Kim ST; Kim JW; Liu W; Sun J; Lu D; Feng J; Zhu Y; Jin T; Zhang Z; Dimitrov L; Lowey J; Campbell K; Suh E; Duggan D; Carpten J; Trent JM; Gronberg H; Zheng SL; Isaacs WB; Xu J
    Prostate; 2012 Mar; 72(4):376-85. PubMed ID: 21671247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
    Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
    PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide pleiotropy scan for prostate cancer risk.
    Panagiotou OA; Travis RC; Campa D; Berndt SI; Lindstrom S; Kraft P; Schumacher FR; Siddiq A; Papatheodorou SI; Stanford JL; Albanes D; Virtamo J; Weinstein SJ; Diver WR; Gapstur SM; Stevens VL; Boeing H; Bueno-de-Mesquita HB; Barricarte Gurrea A; Kaaks R; Khaw KT; Krogh V; Overvad K; Riboli E; Trichopoulos D; Giovannucci E; Stampfer M; Haiman C; Henderson B; Le Marchand L; Gaziano JM; Hunter DJ; Koutros S; Yeager M; Hoover RN; ; Chanock SJ; Wacholder S; Key TJ; Tsilidis KK
    Eur Urol; 2015 Apr; 67(4):649-57. PubMed ID: 25277271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical implications of family history of prostate cancer and genetic risk single nucleotide polymorphism (SNP) profiles in an active surveillance cohort.
    Goh CL; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Thomas K; Selvadurai ED; Woode-Amissah R; Dadaev T; Mahmud N; Castro E; Olmos D; Guy M; Govindasami K; O'Brien LT; Hall AL; Wilkinson RA; Sawyer EJ; Al Olama AA; Easton DF; Kote-Jarai Z; Parker CC; Eeles RA
    BJU Int; 2013 Sep; 112(5):666-73. PubMed ID: 23320731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of recently identified prostate cancer susceptibility loci in a population-based study: associations with family history and clinical features.
    Fitzgerald LM; Kwon EM; Koopmeiners JS; Salinas CA; Stanford JL; Ostrander EA
    Clin Cancer Res; 2009 May; 15(9):3231-7. PubMed ID: 19366831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of replication studies of prostate cancer susceptibility genetic variants in high-risk men originally identified from genome-wide association studies.
    Ishak MB; Giri VN
    Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1599-610. PubMed ID: 21715604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy.
    Merrick GS; Bennett A; Couture T; Butler WM; Galbreath RW; Adamovich E
    Am J Clin Oncol; 2017 Aug; 40(4):353-357. PubMed ID: 25575041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-only Methods Identified Genetic Loci Predicting a Subgroup of Men with Reduced Risk of High-grade Prostate Cancer by Finasteride.
    Dai JY; LeBlanc M; Goodman PJ; Lucia MS; Thompson IM; Tangen CM
    Cancer Prev Res (Phila); 2019 Feb; 12(2):113-120. PubMed ID: 30538099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
    Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
    Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence.
    Ahn J; Kibel AS; Park JY; Rebbeck TR; Rennert H; Stanford JL; Ostrander EA; Chanock S; Wang MH; Mittal RD; Isaacs WB; Platz EA; Hayes RB
    Clin Cancer Res; 2011 Mar; 17(5):1075-81. PubMed ID: 21343373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diabetes mellitus and Metformin administration on prostate cancer detection at biopsy among Chinese men: a case-control study.
    Hu MB; Bai PD; Wu YS; Zhang LM; Zhu WH; Hu JM; Yang T; Jiang HW; Ding Q
    J BUON; 2019; 24(1):227-232. PubMed ID: 30941974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.